DDX5 enhances HIF‐1 activity by promoting the interaction of HIF‐1α with HIF‐1β and recruiting the resulting heterodimer to its target gene loci
Biology of the Cell · 2024
DOI: 10.1111/boc.202300077 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biology of the Cell, 2024. Verfasst von Yukari Shirai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cancer Cell Biology, Graduate School of Biostudies, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Daiichi Sankyo Foundation of Life Science, Suzuken Memorial Foundation, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Background
Information Cancer cells acquire malignant characteristics and therapy resistance by employing the hypoxia‐inducible factor 1 (HIF‐1)‐dependent adaptive response to hypoxic microenvironment in solid tumors. Since the underlying molecular mechanisms remain unclear, difficulties are associated with establishing effective therapeutic strategies.
Results
We herein identified DEAD‐box helicase 5 (DDX5) as a novel activator of HIF‐1 and found that it enhanced the heterodimer formation of HIF‐1α and HIF‐1β and facilitated the recruitment of the resulting HIF‐1 to its recognition sequence, hypoxia‐response element (HRE), leading to the expression of a subset of cancer‐related genes under hypoxia.
Conclusions
This study reveals that the regulation of HIF‐1 recruitment to HRE is an important regulatory step in the control of HIF‐1 activity. Significance The present study provides novel insights for the development of strategies to inhibit the HIF‐1‐dependent expression of cancer‐related genes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Cancer Cell Biology, Graduate School of Biostudies, Kyoto University, Kyoto, Japan.
- Department of Genome Repair Dynamics, Radiation Biology Center, Graduate School of Biostudies, Kyoto University, Kyoto, Japan.
- Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.
- Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
ORCID-Profile: Yukari Shirai, Minoru Kobayashi, Hiroshi Harada
Förderung
- Daiichi Sankyo Foundation of Life Science
- Suzuken Memorial Foundation
- Japan Agency for Medical Research and Development
- Princess Takamatsu Cancer Research Fund
- Japan Society for the Promotion of Science
- Takeda Science Foundation
- Uehara Memorial Foundation
- Kobayashi Foundation for Cancer Research
Zitieren
APA
Shirai, Y., Suwa, T., Kobayashi, M., Koyasu, S., & Harada, H. (2024). DDX5 enhances HIF‐1 activity by promoting the interaction of HIF‐1α with HIF‐1β and recruiting the resulting heterodimer to its target gene loci. Biology of the Cell. https://doi.org/10.1111/boc.202300077
Vancouver
Shirai Y, Suwa T, Kobayashi M, Koyasu S, Harada H. DDX5 enhances HIF‐1 activity by promoting the interaction of HIF‐1α with HIF‐1β and recruiting the resulting heterodimer to its target gene loci. Biology of the Cell. 2024. doi:10.1111/boc.202300077
BibTeX
@article{Shirai2024,
author = {Shirai, Yukari and Suwa, Tatsuya and Kobayashi, Minoru and Koyasu, Sho and Harada, Hiroshi},
title = {DDX5 enhances HIF‐1 activity by promoting the interaction of HIF‐1α with HIF‐1β and recruiting the resulting heterodimer to its target gene loci},
journal = {Biology of the Cell},
year = {2024},
doi = {10.1111/boc.202300077}
}
EUVIMED